- Home
- MTB vs IQV Comparison
MTB vs IQV Comparison
Compare MTB & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTB
- IQV
- Stock Information
- Founded
- MTB 1856
- IQV 1982
- Country
- MTB United States
- IQV United States
- Employees
- MTB N/A
- IQV N/A
- Industry
- MTB Major Banks
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MTB Finance
- IQV Health Care
- Exchange
- MTB Nasdaq
- IQV Nasdaq
- Market Cap
- MTB 29.9B
- IQV 31.6B
- IPO Year
- MTB N/A
- IQV 2013
- Fundamental
- Price
- MTB $179.63
- IQV $174.35
- Analyst Decision
- MTB Buy
- IQV Strong Buy
- Analyst Count
- MTB 17
- IQV 18
- Target Price
- MTB $218.79
- IQV $248.72
- AVG Volume (30 Days)
- MTB 1.6M
- IQV 1.5M
- Earning Date
- MTB 04-14-2025
- IQV 05-01-2025
- Dividend Yield
- MTB 3.01%
- IQV N/A
- EPS Growth
- MTB N/A
- IQV 2.74
- EPS
- MTB 14.64
- IQV 7.49
- Revenue
- MTB $8,669,000,000.00
- IQV $15,405,000,000.00
- Revenue This Year
- MTB $12.97
- IQV $4.25
- Revenue Next Year
- MTB $4.57
- IQV $6.17
- P/E Ratio
- MTB $12.27
- IQV $23.21
- Revenue Growth
- MTB N/A
- IQV 2.81
- 52 Week Low
- MTB $133.03
- IQV $169.11
- 52 Week High
- MTB $225.70
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- MTB 47.48
- IQV 35.36
- Support Level
- MTB $173.13
- IQV $169.37
- Resistance Level
- MTB $185.66
- IQV $188.39
- Average True Range (ATR)
- MTB 4.18
- IQV 4.83
- MACD
- MTB 0.83
- IQV -0.79
- Stochastic Oscillator
- MTB 58.44
- IQV 25.16
About MTB M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.